Koninklijke DSM N.V. Stock Other OTC
Equities
RDSMY
US7802491081
Consumer Goods Conglomerates
Sales 2024 * | 12.6B 13.5B 18.43B | Sales 2025 * | 13.28B 14.22B 19.42B | Capitalization | 27.82B 29.79B 40.68B |
---|---|---|---|---|---|
Net income 2024 * | 448M 480M 655M | Net income 2025 * | 801M 858M 1.17B | EV / Sales 2024 * | 2.43 x |
Net Debt 2024 * | 2.85B 3.05B 4.16B | Net Debt 2025 * | 2.58B 2.76B 3.77B | EV / Sales 2025 * | 2.29 x |
P/E ratio 2024 * |
61.2
x | P/E ratio 2025 * |
35
x | Employees | - |
Yield 2024 * |
2.39% | Yield 2025 * |
2.35% | Free-Float | 25.03% |
Latest transcript on Koninklijke DSM N.V.
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 89-12-31 | |
Ralf Schmeitz
DFI | Director of Finance/CFO | - | 23-08-31 |
Sarah Reisinger
CTO | Chief Tech/Sci/R&D Officer | 45 | 22-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 23-01-31 | |
Thomas Leysen
CHM | Chairman | 63 | 23-01-31 |
Director/Board Member | 62 | 23-01-31 |
1st Jan change | Capi. | |
---|---|---|
+14.41% | 894B | |
+2.13% | 246B | |
+25.15% | 176B | |
+2.26% | 141B | |
+73.55% | 97.11B | |
-9.16% | 72.39B | |
-6.65% | 56.99B | |
+102.40% | 33.95B | |
-34.89% | 33.49B |